Zeitschriftenartikel zum Thema „Β1-Blockers“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Β1-Blockers" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Bennett, Miriam, Catherina L. Chang, Michael Tatley, Ruth Savage und Robert J. Hancox. „The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports“. ERJ Open Research 7, Nr. 1 (Januar 2021): 00801–2020. http://dx.doi.org/10.1183/23120541.00801-2020.
Der volle Inhalt der Quelledo Vale, Gabriel T., Carla S. Ceron, Natália A. Gonzaga, Janaina A. Simplicio und Júlio C. Padovan. „Three Generations of β-blockers: History, Class Differences and Clinical Applicability“. Current Hypertension Reviews 15, Nr. 1 (29.01.2019): 22–31. http://dx.doi.org/10.2174/1573402114666180918102735.
Der volle Inhalt der QuelleKaroli, N. A., und A. P. Rebrov. „Possibilities and limitations of the use of beta-blockers in patients with cardiovascular disease and chronic obstructive pulmonary disease“. Kardiologiia 61, Nr. 10 (30.10.2021): 89–98. http://dx.doi.org/10.18087/cardio.2021.10.n1119.
Der volle Inhalt der QuelleStănciulescu, Maria-Corina, Marius-Călin Popoiu, Anca Maria Cîmpean, Vlad-Laurentiu David, Rodica Heredea, Simona Cerbu und Eugen-Sorin Boia. „Expression of β1 adrenergic receptor in vascular anomalies in children“. Journal of International Medical Research 49, Nr. 9 (September 2021): 030006052110477. http://dx.doi.org/10.1177/03000605211047713.
Der volle Inhalt der QuelleBarcella, Carlo A., Talip E. Eroglu, Michiel Hulleman, Asger Granfeldt, Patrick C. Souverein, Grimur H. Mohr, Rudolph W. Koster et al. „Association of beta-blockers and first-registered heart rhythm in out-of-hospital cardiac arrest: real-world data from population-based cohorts across two European countries“. EP Europace 22, Nr. 8 (28.06.2020): 1206–15. http://dx.doi.org/10.1093/europace/euaa124.
Der volle Inhalt der QuelleGrande, Fedora, Anna De Bartolo, Maria Antonietta Occhiuzzi, Anna Caruso, Carmine Rocca, Teresa Pasqua, Alessia Carocci, Vittoria Rago, Tommaso Angelone und Maria Stefania Sinicropi. „Carbazole and Simplified Derivatives: Novel Tools toward β-Adrenergic Receptors Targeting“. Applied Sciences 11, Nr. 12 (13.06.2021): 5486. http://dx.doi.org/10.3390/app11125486.
Der volle Inhalt der QuelleArtym, Vira V., und Howard R. Petty. „Molecular Proximity of Kv1.3 Voltage-gated Potassium Channels and β1-Integrins on the Plasma Membrane of Melanoma Cells“. Journal of General Physiology 120, Nr. 1 (10.06.2002): 29–37. http://dx.doi.org/10.1085/jgp.20028607.
Der volle Inhalt der QuelleSingh, Bramah N. „β-Adrenergic Blockers as Antiarrhythmic and Antifibrillatory Compounds: An Overview“. Journal of Cardiovascular Pharmacology and Therapeutics 10, Nr. 4_suppl (Oktober 2005): S3—S14. http://dx.doi.org/10.1177/10742484050100i402.
Der volle Inhalt der QuelleWinther, K., und C. Hedman. „Beta-Adrenoceptor Blockade, Platelets, and Rheologic Factors“. Cephalalgia 6, Nr. 5_suppl (Mai 1986): 33–40. http://dx.doi.org/10.1177/03331024860060s504.
Der volle Inhalt der QuelleDiniz, Gabriela Placoná, Marcela Sorelli Carneiro-Ramos und Maria Luiza Morais Barreto-Chaves. „Thyroid Hormone Increases TGF-β1 in Cardiomyocytes Cultures Independently of Angiotensin II Type 1 and Type 2 Receptors“. International Journal of Endocrinology 2010 (2010): 1–7. http://dx.doi.org/10.1155/2010/384890.
Der volle Inhalt der QuelleClemente-Moragón, Agustín, Mónica Gómez, Rocío Villena-Gutiérrez, Doménica V. Lalama, Jaime García-Prieto, Fernando Martínez, Fátima Sánchez-Cabo, Valentín Fuster, Eduardo Oliver und Borja Ibáñez. „Metoprolol exerts a non-class effect against ischaemia–reperfusion injury by abrogating exacerbated inflammation“. European Heart Journal 41, Nr. 46 (07.10.2020): 4425–40. http://dx.doi.org/10.1093/eurheartj/ehaa733.
Der volle Inhalt der QuelleNuttall, S. L., H. C. Routledge und M. J. Kendall. „A comparison of the β1 -selectivity of three β1 -selective β-blockers“. Journal of Clinical Pharmacy and Therapeutics 28, Nr. 3 (Juni 2003): 179–86. http://dx.doi.org/10.1046/j.1365-2710.2003.00477.x.
Der volle Inhalt der QuelleWAJIMA, Zen'ichiro. „Future Possibilities for the Clinical Use of β1-blockers“. JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA 26, Nr. 4 (2006): 398–403. http://dx.doi.org/10.2199/jjsca.26.398.
Der volle Inhalt der QuelleNakaya, Michio, Satsuki Chikura, Kenji Watari, Natsumi Mizuno, Koji Mochinaga, Supachoke Mangmool, Satoru Koyanagi et al. „Induction of Cardiac Fibrosis by β-Blocker in G Protein-independent and G Protein-coupled Receptor Kinase 5/β-Arrestin2-dependent Signaling Pathways“. Journal of Biological Chemistry 287, Nr. 42 (10.08.2012): 35669–77. http://dx.doi.org/10.1074/jbc.m112.357871.
Der volle Inhalt der QuelleÁblad, Bengt, und Carl Dahlöf. „Migraine and β-Blockade: Modulation of Sympathetic Neurotransmission“. Cephalalgia 6, Nr. 5_suppl (Mai 1986): 7–14. http://dx.doi.org/10.1177/03331024860060s501.
Der volle Inhalt der QuelleBlaauw, Erik, Frans A. van Nieuwenhoven, Peter Willemsen, Tammo Delhaas, Frits W. Prinzen, Luc H. Snoeckx, Marc van Bilsen und Ger J. van der Vusse. „Stretch-induced hypertrophy of isolated adult rabbit cardiomyocytes“. American Journal of Physiology-Heart and Circulatory Physiology 299, Nr. 3 (September 2010): H780—H787. http://dx.doi.org/10.1152/ajpheart.00822.2009.
Der volle Inhalt der QuelleAshes, Catherine, Saul Judelman, Duminda N. Wijeysundera, Gordon Tait, C. David Mazer, Gregory M. T. Hare und W. Scott Beattie. „Selective β1-Antagonism with Bisoprolol Is Associated with Fewer Postoperative Strokes than Atenolol or Metoprolol“. Anesthesiology 119, Nr. 4 (01.10.2013): 777–87. http://dx.doi.org/10.1097/aln.0b013e3182a17f12.
Der volle Inhalt der QuellePeltenburg, Puck J., Dania Kallas, Johan M. Bos, Krystien V. V. Lieve, Sonia Franciosi, Thomas M. Roston, Isabelle Denjoy et al. „An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia“. Circulation 145, Nr. 5 (Februar 2022): 333–44. http://dx.doi.org/10.1161/circulationaha.121.056018.
Der volle Inhalt der QuelleDurgaryan, Ruzan. „C0159 β1 blockers, warfarin and rhythm conversion in atrial fibrillation“. Thrombosis Research 130 (Oktober 2012): S173. http://dx.doi.org/10.1016/j.thromres.2012.08.188.
Der volle Inhalt der QuelleFedorov, V. N., V. P. Vdovichenko, M. K. Korsakov, V. V. Strakhov, A. A. Popova, A. I. Khokhlov und S. S. Suleymanov. „Pharmacotherapy of glaucoma in terms of evidence-based medicine“. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice, Nr. 3 (20.10.2023): 44–54. http://dx.doi.org/10.37489/2588-0519-2023-3-44-54.
Der volle Inhalt der QuelleGeng, Yanyan, Xiaoyu Wang und Karl L. Magleby. „Lack of negative slope in I-V plots for BK channels at positive potentials in the absence of intracellular blockers“. Journal of General Physiology 141, Nr. 4 (25.03.2013): 493–97. http://dx.doi.org/10.1085/jgp.201210955.
Der volle Inhalt der QuelleYi, Sheng, Fernando Pierucci-Alves und Bruce D. Schultz. „Transforming growth factor-β1 impairs CFTR-mediated anion secretion across cultured porcine vas deferens epithelial monolayer via the p38 MAPK pathway“. American Journal of Physiology-Cell Physiology 305, Nr. 8 (15.10.2013): C867—C876. http://dx.doi.org/10.1152/ajpcell.00121.2013.
Der volle Inhalt der QuelleCasabella-Ramón, Sergi, Verónica Jiménez-Sábado, Carmen Tarifa, Sandra Casellas, Tien Tina Lu, Paloma Izquierdo-Castro, Ignasi Gich et al. „Impact of R-Carvedilol on β2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes“. Biomedicines 10, Nr. 7 (21.07.2022): 1759. http://dx.doi.org/10.3390/biomedicines10071759.
Der volle Inhalt der QuelleFarhoumand, Lina S., Hongtao Liu, Theodora Tsimpaki, Ulrike B. Hendgen-Cotta, Tienush Rassaf, Nikolaos E. Bechrakis, Miltiadis Fiorentzis und Utta Berchner-Pfannschmidt. „Blockade of ß-Adrenergic Receptors by Nebivolol Enables Tumor Control Potential for Uveal Melanoma in 3D Tumor Spheroids and 2D Cultures“. International Journal of Molecular Sciences 24, Nr. 6 (20.03.2023): 5894. http://dx.doi.org/10.3390/ijms24065894.
Der volle Inhalt der QuelleWydra, Wioletta, und Marek Kuch. „Nebivolol – a place in the therapy of hypertension in various clinical situations“. Medycyna Faktów 14, Nr. 2 (30.06.2021): 195–200. http://dx.doi.org/10.24292/01.mf.0221.9.
Der volle Inhalt der QuelleVerdecchia, Paolo, Claudio Cavallini, Stefano Coiro, Clara Riccini und Fabio Angeli. „Certainties fading away: β-blockers do not worsen chronic obstructive pulmonary disease“. European Heart Journal Supplements 23, Supplement_E (01.10.2021): E172—E176. http://dx.doi.org/10.1093/eurheartj/suab116.
Der volle Inhalt der QuelleFloria, Mariana, Alexandru Florinel Oancea, Paula Cristina Morariu, Alexandru Burlacu, Diana Elena Iov, Cristina Petronela Chiriac, Genoveva Livia Baroi et al. „An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation“. Pharmaceutics 16, Nr. 4 (08.04.2024): 517. http://dx.doi.org/10.3390/pharmaceutics16040517.
Der volle Inhalt der QuelleSchnabel, Petra, Christoph Maack, Florian Mies, Stephan Tyroller, Alexander Scheer und Michael Böhm. „Binding Properties of β-Blockers at Recombinant β1-, β2-, and β3-Adrenoceptors“. Journal of Cardiovascular Pharmacology 36, Nr. 4 (Oktober 2000): 466–71. http://dx.doi.org/10.1097/00005344-200010000-00008.
Der volle Inhalt der QuelleMizogami, Maki, Ko Takakura und Hironori Tsuchiya. „The interactivities with lipid membranes differentially characterize selective and nonselective β1-blockers“. European Journal of Anaesthesiology 27, Nr. 9 (September 2010): 829–34. http://dx.doi.org/10.1097/eja.0b013e32833bf5e4.
Der volle Inhalt der Quelle&NA;. „The interactivities with lipid membranes differentially characterize selective and nonselective β1-blockers“. European Journal of Anaesthesiology 29, Nr. 5 (Mai 2012): 255. http://dx.doi.org/10.1097/eja.0b013e328353b02b.
Der volle Inhalt der QuelleBrizzi, Vittorio, Marco Francioli, Mario Brufani, Luigi Filocamo, Giancarlo Bruni und Paola Massarelli. „Synthesis, binding affinity and selectivity of new β1- and β2-adrenoceptor blockers“. Il Farmaco 54, Nr. 11-12 (November 1999): 713–20. http://dx.doi.org/10.1016/s0014-827x(99)00077-4.
Der volle Inhalt der QuelleRizos, Ioannis K., James N. Tsoporis, Ioannis K. Toumpoulis, Vasileios Salpeas, Shehla Izhar, Angelos G. Rigopoulos, Eleftherios A. Sakadakis und Thomas G. Parker. „Antiapoptotic Effect of β1 Blockers in Ascending Thoracic Aortic Smooth Muscle Cells“. Journal of Cardiovascular Pharmacology 72, Nr. 2 (August 2018): 86–96. http://dx.doi.org/10.1097/fjc.0000000000000596.
Der volle Inhalt der QuelleChaudhari, Sarika, Weizu Li, Yanxia Wang, Hui Jiang, Yuhong Ma, Mark E. Davis, Jonathan E. Zuckerman und Rong Ma. „Store-operated calcium entry suppressed the TGF-β1/Smad3 signaling pathway in glomerular mesangial cells“. American Journal of Physiology-Renal Physiology 313, Nr. 3 (01.09.2017): F729—F739. http://dx.doi.org/10.1152/ajprenal.00483.2016.
Der volle Inhalt der QuelleKähönen, Mika, Ritva Ylitalo, Tiit Kööbi, Väinö Turjanmaa und Pauli Ylitalo. „Influences of nonselective, β1-selective and vasodilatory β1-selective β-blockers on arterial pulse wave velocity in normotensive subjects“. General Pharmacology: The Vascular System 35, Nr. 4 (Oktober 2000): 219–24. http://dx.doi.org/10.1016/s0306-3623(01)00109-4.
Der volle Inhalt der QuelleMiaron, J. O. O., und R. J. Christopherson. „Metabolic responses of the whole body, portal-drained viscera and hindquarter to adrenaline infusion: Effects of nonselective and selective β-adrenoceptor blockade“. Canadian Journal of Animal Science 77, Nr. 2 (01.06.1997): 307–16. http://dx.doi.org/10.4141/a94-082.
Der volle Inhalt der QuelleZhang, Y. Clare, Leping Shen und M. Ian Phillips. „An Antisense β1-Reducer: Repeated Administration Reduces Hypertension and Cardiac Hypertrophy Persistently Without Toxicity or Immune Response“. Hypertension 36, suppl_1 (Oktober 2000): 691. http://dx.doi.org/10.1161/hyp.36.suppl_1.691.
Der volle Inhalt der QuelleOngali, Brice, Nektaria Nicolakakis, Xin-Kang Tong, Clotilde Lecrux, Hans Imboden und Edith Hamel. „Transforming growth factor-β1 induces cerebrovascular dysfunction and astrogliosis through angiotensin II type 1 receptor-mediated signaling pathways“. Canadian Journal of Physiology and Pharmacology 96, Nr. 5 (Mai 2018): 527–34. http://dx.doi.org/10.1139/cjpp-2017-0640.
Der volle Inhalt der QuellePark, Soo Hyun, und Ho Jae Han. „The mechanism of angiotensin II binding downregulation by high glucose in primary renal proximal tubule cells“. American Journal of Physiology-Renal Physiology 282, Nr. 2 (01.02.2002): F228—F237. http://dx.doi.org/10.1152/ajprenal.00080.2001.
Der volle Inhalt der QuelleOzakca, Isil, Ebru Arioglu-Inan, Hrag Esfahani, V. Melih Altan, Jean-Luc Balligand, Gizem Kayki-Mutlu und A. Tanju Ozcelikay. „Nebivolol prevents desensitization of β-adrenoceptor signaling and induction of cardiac hypertrophy in response to isoprenaline beyond β1-adrenoceptor blockage“. American Journal of Physiology-Heart and Circulatory Physiology 304, Nr. 9 (01.05.2013): H1267—H1276. http://dx.doi.org/10.1152/ajpheart.00352.2012.
Der volle Inhalt der QuelleKruik-Kollöffel, Willemien J., Job van der Palen, Carine J. M. Doggen, Marissa C. van Maaren, H. Joost Kruik, Edith M. Heintjes, Kris L. L. Movig und Gerard C. M. Linssen. „Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases“. PLOS ONE 15, Nr. 12 (22.12.2020): e0244231. http://dx.doi.org/10.1371/journal.pone.0244231.
Der volle Inhalt der QuelleGutierrez, Guillermo, und Guillermo Ballarino. „Gut mucosal permeability, β1 receptor blockers and gastric tonometry: the time is now!“ Intensive Care Medicine 37, Nr. 11 (17.08.2011): 1721–22. http://dx.doi.org/10.1007/s00134-011-2330-1.
Der volle Inhalt der QuelleNemoto, Shinji, Yusuke Kasahara, Kazuhiro P. Izawa, Satoshi Watanabe, Kazuya Yoshizawa, Naoya Takeichi, Kentaro Kamiya et al. „Effects of αβ-Blocker Versus β1-Blocker Treatment on Heart Rate Response During Incremental Cardiopulmonary Exercise in Japanese Male Patients with Subacute Myocardial Infarction“. International Journal of Environmental Research and Public Health 16, Nr. 16 (08.08.2019): 2838. http://dx.doi.org/10.3390/ijerph16162838.
Der volle Inhalt der QuelleBrahmbhatt, Shruti Vihang, und Bhagya M. Sattigeri. „A study on management of hypertension in patients with type 2 diabetes mellitus in tertiary care teaching rural hospital“. International Journal of Basic & Clinical Pharmacology 7, Nr. 11 (23.10.2018): 2196. http://dx.doi.org/10.18203/2319-2003.ijbcp20184327.
Der volle Inhalt der QuellePillozzi, Serena, Marika Masselli, Emanuele De Lorenzo, Benedetta Accordi, Emanuele Cilia, Olivia Crociani, Amedeo Amedei et al. „Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers“. Blood 117, Nr. 3 (20.01.2011): 902–14. http://dx.doi.org/10.1182/blood-2010-01-262691.
Der volle Inhalt der QuellePolakovičová, M., und R. Čižmáriková. „Molecular Docking Study on the Binding Mode of Cardioselective Phenoxyaminopropanol Blocker into β-adrenergic Receptor Subtypes“. Acta Facultatis Pharmaceuticae Universitatis Comenianae 59, Nr. 2 (28.12.2012): 44–53. http://dx.doi.org/10.2478/v10219-012-0024-6.
Der volle Inhalt der QuelleAhmed, Maruf, Habib Abul Muntasir, Murad Hossain, Masaji Ishiguro, Tadazumi Komiyama, Ikunobu Muramatsu, Hitoshi Kurose und Takafumi Nagatomo. „Beta-Blockers Show Inverse Agonism to a Novel Constitutively Active Mutant of β1-Adrenoceptor“. Journal of Pharmacological Sciences 102, Nr. 2 (2006): 167–72. http://dx.doi.org/10.1254/jphs.fp0060640.
Der volle Inhalt der QuelleSong, Hong Ji, Joongyub Lee, Ye-Jee Kim, Sun-Young Jung, Hwa Jung Kim, Nam-Kyong Choi und Byung-Joo Park. „β1 selectivity of β-blockers and reduced risk of fractures in elderly hypertension patients“. Bone 51, Nr. 6 (Dezember 2012): 1008–15. http://dx.doi.org/10.1016/j.bone.2012.08.126.
Der volle Inhalt der QuelleBrizzi, Vittorio, Marco Francioli, Mario Brufani, Luigi Filocamo, Giancarlo Bruni und Paola Massarelli. „ChemInform Abstract: Synthesis, Binding Affinity, and Selectivity of New β1- and β2-Adrenoceptor Blockers.“ ChemInform 31, Nr. 12 (09.06.2010): no. http://dx.doi.org/10.1002/chin.200012248.
Der volle Inhalt der QuelleJia, Haiyan, Sue Monteith und Morris J. Brown. „Expression of the α- and β-Subunits of the Stimulatory and Inhibitory G-Proteins in β1-Adrenoceptor-Blocked and non-β-Adrenoceptor-Blocked Human Atrium“. Clinical Science 88, Nr. 5 (01.05.1995): 571–80. http://dx.doi.org/10.1042/cs0880571.
Der volle Inhalt der QuelleGao, Xiaomeng, Jingyue Chang, Yi Chang, Lili Fan, Ziqian Liu, Cuijuan Zhang, Tatsuo Shimosawa, Fan Yang und Qingyou Xu. „Esaxerenone Inhibits Renal Angiogenesis and Endothelial-Mesenchymal Transition via the VEGFA and TGF-β1 Pathways in Aldosterone-Infused Mice“. International Journal of Molecular Sciences 24, Nr. 14 (21.07.2023): 11766. http://dx.doi.org/10.3390/ijms241411766.
Der volle Inhalt der Quelle